NASDAQ · HIT

Health In Tech, Inc.

$1.09 +$0.03 (+2.83%) 1D Market open

Key Metrics

$69.49M
Market cap
P/E · TTM
$34.08M
Revenue · TTM
−$808.03K
Net income
EPS · TTM $-0.01
Dividend yield
Free cash flow
Beta · 1Y 1.51
EBITDA · TTM $89.46K
Gross margin 58.9%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 26
    From its Mar 9 high, the share price fell 57%.

    Peak close $2.03 on Mar 9; trough close $0.87 on May 26. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -57%
  • May 14
    The stock moved -20.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 14
  • Apr 21
    The stock moved +14.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 21

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$69.49M
Enterprise value
Shares outstanding65.6M
52-wk range$0.85 – $4.02
Avg volume · 20D725.6K
Net cash
Book value / share$0.38
IndustryInsurance Agents, Brokers & Service
ExchangeNASDAQ
About Health In Tech, Inc.
IPO dateDec 23, 2024
Employees91

Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S2.04
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 58.9%
Operating -3.2%
Net -2.4%
FCF
ROE / ROIC -4.6% · -7.2%

Financial Health

Current ratio3.13
Quick ratio
Debt / equity
Debt / EBITDA
Net cash
Working capital$15.04M

Cash Flow · TTM

Operating CF −$712.79K
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

7.5
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings